American International Group, Inc. Neurocrine Biosciences Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $134,572 - $148,339	-1,032 Reduced 0.77%	132,511 $18.3 Million
Q4 2023 Feb 13, 2024	SELL	$106.07 - $132.76 $519,212 - $649,860	-4,895 Reduced 3.54%	133,543 $17.6 Million
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $908,609 - $1.13 Million	-9,664 Reduced 6.53%	138,438 $15.6 Million
Q2 2023 Aug 04, 2023	SELL	$89.53 - $104.87 $123,999 - $145,244	-1,385 Reduced 0.93%	148,102 $14 Million
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $65,782 - $85,990	-699 Reduced 0.47%	149,487 $15.1 Million
Q4 2022 Feb 10, 2023	SELL	$106.72 - $127.06 $130,198 - $155,013	-1,220 Reduced 0.81%	150,186 $17.9 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $642,921 - $753,160	-6,986 Reduced 4.41%	151,406 $16.1 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $234,949 - $310,217	-3,100 Reduced 1.92%	158,392 $15.4 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $22,024 - $28,822	304 Added 0.19%	161,492 $15.1 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $206,851 - $275,853	-2,597 Reduced 1.59%	161,188 $13.7 Million
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $427,969 - $491,782	-4,966 Reduced 2.94%	163,785 $15.7 Million
Q2 2021 Aug 13, 2021	SELL	$89.43 - $102.27 $220,087 - $251,686	-2,461 Reduced 1.44%	168,751 $16.4 Million
Q1 2021 May 07, 2021	BUY	$87.57 - $119.4 $14.8 Million - $20.2 Million	168,902 Added 7311.77%	171,212 $16.7 Million
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $8,430 - $10,508	-97 Reduced 4.03%	2,310 $221,000
Q3 2020 Nov 04, 2020	SELL	$96.16 - $135.15 $10,481 - $14,731	-109 Reduced 4.33%	2,407 $232,000
Q2 2020 Aug 12, 2020	BUY	$85.09 - $130.36 $37,269 - $57,097	438 Added 21.08%	2,516 $307,000
Q1 2020 May 04, 2020	SELL	$75.11 - $113.76 $3,079 - $4,664	-41 Reduced 1.93%	2,078 $180,000
Q4 2019 Feb 05, 2020	SELL	$86.8 - $118.57 $7,812 - $10,671	-90 Reduced 4.07%	2,119 $228,000
Q2 2019 Aug 13, 2019	BUY	$72.24 - $91.27 $9,318 - $11,773	129 Added 6.2%	2,209 $187,000
Q1 2019 May 06, 2019	SELL	$69.31 - $91.53 $5,128 - $6,773	-74 Reduced 3.44%	2,080 $183,000
Q2 2018 Aug 08, 2018	BUY	$75.3 - $105.99 $10,014 - $14,096	133 Added 6.58%	2,154 $212,000
Q1 2018 May 07, 2018	SELL	$75.88 - $92.43 $3,642 - $4,436	-48 Reduced 2.32%	2,021 $168,000
Q4 2017 Feb 09, 2018	BUY	$58.53 - $77.59 $121,098 - $160,533	2,069	2,069 $161,000

Others Institutions Holding NBIX

# of Institutions

632

Shares Held

93.9M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.43 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$738 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$369 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$267 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account